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It has been proposed that considerable DNA damage may be caused by 
endogenous metabolites produced during the body's normal metabolic processes. For 
example, it has been shown that malondialdehyde which is the ubiquitous product of 
lipid peroxidation and eicosanoid metabolism reacts with cellular DNA to form a 
propanodeoxy-guanosine adduct. Evidence indicates that the adduct exists at 
significant levels in the hepatic DNA of rats and humans and is an efficient 
premutagenic lesion in E.coli. Dopamine formed by the decarboxylation of L-3,4-
dihydroxyphenylalanine (L-DOPA), condenses with acetaldehyde, a product of 
ethanol metabolism, to generate l-methyl-6,7-dihydroxy-l,2,3,4-tetrahydroiso-
quinoline (salsolinol). Salsolinol is considered to be involved in the etiology of 
Parkinson's and Huntington's diseases and has been detected in the cerebrospinal 
fluid of Parkinsonian patients. It has also been shown to cause strand breakage in 
DNA and cell death in the presence of copper ions. Thus, there is growing evidence 
that endogenous substrates may be an important source of cancer inducing damage to 
cellular DNA as the adducts formed may attribute to the etiology of genetic disease 
and therein the baseline of human cancer. 
It has been shown that several metabolites such as L-DOPA and dopamine cause 
oxidative DNA breakage in the presence of copper ions. Copper is a normal 
component of chromatin and is available for intemucleosomal DNA fragmentation. 
5-hydroxytryptamine or serotonin is an important neurotransmitter in brain and spinal 
cord and is involved in the control of sleep and consciousness, aggression and mood. 
In a recent report it was shown that copper ions are capable of binding to serotonin. It 
was therefore of interest to examine whether serotonin may also cause DNA cleavage 
through an oxidative mechanism. In this thesis I describe experiments to show that 
this is indeed the case and such DNA breakage results from the generation of the 
hydroxyl radical. This forms part-I of the results. In the Ilnd-part, I have examined the 
mechanism of copper binding by serotonin and have proposed a model for the same. 
DNA cleavage by serotonin and Cu(II) was detected by using supercoiled 
plasmid DNA, as the relaxation of such a molecule is a sensitive test for a single nick. 
The results showed that serotonin converted supercoiled DNA to relaxed open circles 
in a dose dependent reaction. In order to examine the involvement of Cu(I) in the 
reaction, we used bathocuproine as an agent that sequesters Cu(I) selectively. 
Serotonin reduces Cu(II) to generate Cu(I) as evidenced by the formation of a 
complex absorbing at 480 nm. The stoichiometry of Cu(II) reduction by serotonin was 
also determined and it was shown that 1 mole of free serotonin is capable of reducing 
2 moles of Cu(II). It was further shown that serotonin-Cu(II) complex generates 
hydroxyl radicals as evidenced by aromatic hydroxylation of salicylate. In the 
presence of Cu(II) and with increasing concentrations of serotonin an increasing 
degree of hydroxyl radical formation was seen. The addition of DNA to serotonin 
solutions causes a decrease in fluorescence emission of serotonin at 335 nm and a 
decreasing degree of fluorescence is seen with increasing concentrations of DNA. The 
results indicate that similar to L-DOPA, serotonin is also capable of binding to DNA. 
In order to examine the chemical basis of the DNA cleavage activity of serotonin-
Cu(II) complex, the relative efficiency of serotonin was compared with the 
structurally related metabolites; tryptophan and melatonin. Full conversion of the 
supercoiled molecules to the open circular forms was seen with serotonin only. Thus, 
the property of serotonin to cleave DNA in the presence of Cu(II) can be almost 
entirely attributed to the phenolic group, as the methoxylation of this group in 
melatonin considerably diminished the DNA cleavage activity. It was also shown that 
the addition of Cu(II) causes an enhancement of the serotonin absorption band, 
indicating an interaction of copper ions with serotonin. Such enhancement was not 
seen with melatonin and tryptophan. These results correlate with the ability of 
serotonin-Cu(II) complex to degrade DNA. 
The serotonin-Cu(II) DNA cleavage reaction was further characterized with 
respect to its relevance to biological systems. It was shown that the reaction is capable 
of inactivating bacteriophage T4. It was also established that phage inactivation is 
quenched by oxygen radical quenchers, suggesting that the mechanism of 
bacteriophage inactivation is possibly the same as that of the DNA cleavage reaction. 
Serotonin-Cu(II) system is also capable of causing protein fragmentation. In addition 
to fragmentation, the action on proteins results in enhanced reducing capacity of 
modified proteins. This was established by demonstrating that modified BSA reduces 
Cu(II) to generate Cu(I) at an enhanced rate as compared with unmodified BSA. 
In the Ilnd-part of the results, I have examined the mechanism of copper binding 
by serotonin, using absorption spectral studies, copper mediated lipid peroxidation 
and by determining the oxidation of the serotonin molecule. Addition of increasing 
concentrations of Cu(II) to serotonin leads to a progressive enhancement in the 
absorption band and is accompanied by a shift towards lower wavelength indicative of 
the formation of an oxidized species of serotonin. Studies with the structurally related 
molecules; tryptophan and melatonin, showed that only serotonin is able to reduce 
Cu(II) to Cu(I). Similarly, only serotonin was found to be able to abolish the copper 
mediated peroxidation of mitochondria. These results suggested the involvement of 
the phenolic group in copper binding. Further, it was also shown that the binding of 
copper to serotonin leads to the formation of a quinone in the absence of molecular 
oxygen. Based on the results, a model has been proposed in which serotonin reduces 
two molar equivalents of Cu(II) to Cu(I) through a reaction involving two electron 
oxidation of phenolic ring to a quinone methide. 
Progressive accumulation of genetic mutations is thought to be central to the 
process of tumorigenesis and aging. Most of the critical genes that are mutated during 
the development of human cancer can be broadly classified as either proto-oncogenes 
or tumor suppressor genes. Although the concentrations of serotonin used in the 
above experiments (lOjjM and above) do not approach the in vivo levels (0.2-1.14|xM 
in blood), DNA breakage in the presence of copper ions is also shown by other 
metabolites. It is conceivable that the cumulative effect of such endogenous 
metabolites could be of physiological significance and could contribute to the etiology 
of genetic disease. 
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There has been an increasing reaHzation in recent years that endogenous 
substrates may be an important source of cancer inducing damage to cellular DNA. 
Therefore, the role of endogenous genotoxins in tumorigenesis has emerged as an 
important research area as a result of the detection of a variety of adducts derived 
from endogenous electrophiles in human DNA. Several classes of endogenous 
adducts and modified bases have been detected in DNA of normal cells. These 
include oxidised, alkylated and exocyclic bases and a series of unidentified putative 
adducts called I-compounds (Marnett and Burcham, 1993). Generation of oxidised 
bases such as 8-OH guanine by reaction of DNA with intracellular oxidants is 
quantitatively the most important class of base modification in mammalian cells. The 
nature and origin of the oxidants responsible for these lesions are not known with 
certainty, but leakage of reactive oxygen' species during oxidations in the 
mitochondria and the endoplasmic reticulum are considered the likely sources. 
Oxygen radicals and human disease 
It is well established that aerobic organisms produce reactive oxygen species 
during the course of normal metabolism. These include superoxide anion, hydrogen 
peroxide and the hydroxyl radical (Fridovich", 1989; Sies, 1991; Weiss, 1989). 
Oxidative DNA damage by these species has been implicated in a number of human 
diseases including cancer (Loft and Paulson, 1996). The other diseases where such 
damage may play an important role are rheumatoid arthritis (Gridley et al, 1993), 
Alzheimer's disease, Parkinson's disease and Amyotropic Lateral Sclerosis (ALS) 
(Sanchez-Ramos and Ames, 1994; Mecocci et al, 1994; Robberecht et al, 1994). In 
ALS it has been suggested that the lack of superoxide dismutase (SOD) activity or a 
mutant form of this enzyme may be an important factor (Spencer et al, 1994). In 
addition, oxygen radical toxicity is considered to be the cause of human male 
infertility (Aitken and Fisher, 1994) and the aging process in humans (Loft and 
Paulson, 1996). One of the theories for the etiology of cancer which is being widely 
accepted, holds that the major cause is damage to DNA by oxygen radicals and lipid 
peroxidation (Ames, 1983; Totter, 1980). The presence of free radicals at the same 
time can be advantageous for cells. Infact, they are being continuously produced in 
organisms and many of them are necessary to carry out certain biological reactions. 
However, when there is a fi"ee radical overproduction or antioxidant defence systems 
are weakened for any reason, cellular damage can appear (Valenzuela and Videla, 
1989; Halliwell etal, 1992). Ionizing radiation, tobacco smoke, pesticide pollutants or 
some medications are exogenous sources of free radicals. Intracellular systems also 
produce free radicals. Several enzymes produce superoxide (O2*) during the 
oxidation of their substrates, for example, xanthine oxidase and peroxidase (Buettner 
et al, 1978; Duran et al, 1977). Numerous substances such as reduced flavins and 
ascorbic acid upon autooxidation produce superoxide anion. This radical further 
accepts an electron from a reducing agent, such as thiols, to yield peroxide (H2O2). 
There is m vitro evidence that H2O2 may then react with certain chelates of copper 
and iron to yield the highly reactive hydroxyl radical (OH*) (Wolff e/ al, 1986). That 
the superoxide anion actually appears in metabolism is confirmed by the ubiquitous 
occurrence of superoxide dismutase. Indeed, certain white blood cells generate 
superoxide deliberately by means of a specialized membrane bound NADPH-oxidase 
and this participates in the killing of microorganisms and tumor cells (Wolff and 
Dean, 1986). 
It has been suggested that certain promoters of carcinogenesis act by generation 
of oxygen radicals, this being a common property of these substances. Reactive 
oxygen species (ROS) produce gross chromosomal alterations in addition to point 
mutations and thus could be involved in the inactivation or loss of the second wild 
type allele of a mutant proto-oncogene or tumor suppressor gene that can occur during 
tumor promotion and progression, allowing expression of the mutated phenotype 
(Wiseman and Halliwell, 1996; Cerutti, 1994). Fat and hydrogen peroxide are among 
the most potent promoters (Welsch and Aylsworth, 1983). Other well known cancer 
promoters are lead, cadmium, phorbol esters, asbestos and various quinones. 
Inflammatory reactions lead to the production of oxygen radicals by phagocytes and 
this ic the basis of cancer promotion by asbestos (Hatch et al, 1980). Many 
carcinogens which do not require the action of promoters and are by themselves able 
to induce carcinogenesis (complete carcinogens), also produce oxygen radicals 
(Demopoulus et al, 1980). These include nitroso compounds, hydrazines, quinones 
and polycyclic hydrocarbons. Much of the toxic effect of ionising radiation damage to 
DNA is also due to the formation of oxygen radicals (Totter, 1980). The mechanism 
of action of promoters involves the expression of recessive genes and an increase in 
the gene copy number through chromosome breaks and creation of hemizygosity 
(Kinsella, 1982; Varshavsky, 1981). Promoters also cause modification of 
prostaglandins which are intimately involved in cell division, differentiation and 
tumor growth (Fischer et al, 1982). Most data on radical damage to biological 
macromolecules concerns with the effects of radiation on nucleic acids because of the 
possible genetic effects. However, in view of the catalytic role of enzymes, damage to 
proteins is also considered important. It has been suggested that primary oxygen 
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radicals, produced in cells and their secondary lipid intermediates modify and 
fragment proteins. The products are often more susceptible to enzymatic hydrolysis 
leading to accelerated proteolysis inside and outside cells (Wolff ef al, 1986). 
Anticarcinogens and antioxidants 
The protective defence mechanisms against mutagens and carcinogens include 
the shedding of surface layer of skin, cornea and the alimentary canal. If oxygen 
radicals play a major role in DNA damage, defence against these agents is obviously 
of great importance (Totter, 1980). The major source of endogenous oxygen radicals 
are hydrogen peroxide and superoxide which are generated as side products of 
metabolism (Pryor, 1976-1982). In addition, oxygen radicals also arise from 
phagocytosis after viral and bacterial infection or in inflammatory reactions (Tauber, 
1982). The exogenous oxygen radical load is contributed by a variety of 
environmental agents (Pryor, 1976-1982). The enzymes that protect cells from 
oxidative damage are superoxide dismutase, glutathione peroxidase (Pryor, 1976-
1982), D.T. diaphorase (Lind etal, 1982) and glutathione transferases (Warholm el al, 
1981). In addition to these enzymes, some small molecules in the human diet act as 
antioxidative agents and presumably have an anticarcinogenic effect. Some of these 
compounds are discussed below. a-Tocopherol (Vitamin E) is an important trap of 
oxygen radicals in membranes (Pryor, 1976-1982) and has been shown to decrease 
the carcinogenic effect of quinones, adriamycin and duanomycin, which are toxic 
because of free radical generation (Ames, 1983). Protective effects of tocopherol 
against radiation induced DNA damage and dimethyl hydrazine induced 
carcinogenesis have also been observed (Beckman et al, 1982). p-Carotene is a potent 
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antioxidant present in the diet and is important in protecting lipid membranes against 
oxidation. Singlet oxygen CO2) is a highly reactive form of oxygen which is 
mutagenic and is mainly generated by pigment mediated transfer of energy of light to 
oxygen. Carotenoids are free radical traps and are remarkably efficient as quenchers 
of singlet oxygen (Packer et al, 1981). p-Carotene and similar polyprenes are also the 
main defence in plant systems against singlet oxygen generated as a byproduct of the 
interaction of light and chlorophyll (Krinsky and Deneke, 1982). Carotenoids have 
been shown to be anticarcinogenic in rats and mice and may also have a similar effect 
in humans (Mathews-Roth, 1982; Peto et al, 1981). Glutathione is present in food as 
one of the major antioxidants and is antimutagenic in cells. Glutathione transferases 
are a major defence against oxidative and alkylating carcinogens (Warholm et al, 
1981). Dietary glutathione is an effective anticarcinogen against aflatoxin (Novi, 
1981). The cellular concentration of glutathione is influenced by dietary sulfur amino 
acids (Tateishi et al, 1981). Selenium, which is present in the active site of glutathione 
peroxidase is another important dietary anticarcinogen. Glutathione peroxidase is 
essential for destroying lipid hydroperoxides and endogenous hydrogen peroxide and 
therefore helps to prevent oxygen radical induced lipid peroxidation (Flohe, 1982). 
Several heavy metal toxins, such as Cd^ "^  (a known carcinogen) and Hg^ "^ , decrease 
glutathione peroxidase activity by interaction with selenium (Flohe, 1982) and by 
inhibiting glutathione-S-transferase synthesis (Sidhu et al, 1997). Ascorbic acid, 
another dietary antioxidant has been shown to be anticarcinogenic in rodents treated 
with light and benzo(a)pyrene (Hartman, 1982). Uric acid is present in high 
concentrations in the blood of humans and is a strong antioxidant (Ames * et al. 
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1981). A low uric acid level has been considered a risk factor in cigarette caused lung 
cancer, however, too high levels may cause gout. 
In addition, edible plants contain a variety of substances such as phenols that 
have been reported to inhibit or enhance carcinogenesis and mutagenesis in 
experimental animals (Ames, 1983). The inhibitory action of such compounds may be 
due to the induction of cytochrome p450 and other metabolic enzymes (Boyd et al, 
1982) and through stimulation of trans membrane proteins such as the p-glycoprotein 
pump which is involved in the efflux of chemical carcinogens (Phang et al, 1993) or 
inhibition of DNA, RNA/protein synthesis in cancer cells (Hirono et al, 1994). The 
optimum levels of dietary antioxidants have not been determined; however, there 
might be a considerable variation among individuals. On the other hand, high doses of 
such compounds may lead to deleterious side effects. The difference in cancer rates of 
various populations are generally considered to be due to environmental and life style 
factors such as smoking, dietary carcinogens and promoters. These differences may 
also be due, in good part, to insufficient amounts of anticarcinogens and other 
protective factors in the diet (Maugh, 1979). 
In the past two decades there has been much emphasis on the induction of cancer 
by occupational and industrial factors. There is a growing recognition that these may 
account for a small fraction of human cancers. It is becoming increasingly clear from 
epidemiological and laboratory data that diet is an important factor in the etiology of 
certain human cancers. It has been suggested by Doll and Peto (1981) that in the 
United States, diet accounts for 35% of cancer deaths. According to these authors, 
there are five possible ways whereby diet may affect the incidence of cancer; 
(i) ingestion of powerful, direct acting carcinogens or their precursors, (ii) affecting 
13 
the formation of carcinogens in the body, (iii) affecting transport, activation or 
inactivation of carcinogens, (iv) affecting 'promotion' of cells that are already 
initiated and (v) over nutrition. Normal individual consumption of potentially 
mutagenic substances per day from foods and beverages is estimated to be between 1 
to 2 grams. In addition, endogenous conditions favour the formation of still more 
mutagens in vivo in humans (Oshshima and Bartsch, 1981). 
The antioxidants of human extracellular fluids 
An antioxidant is defined as any substance that, when present at low 
concentrations, compared to those of an oxidisable substrate, significantly delays or 
inhibits the oxidation of that substrate (Halliwell and Gutteridge, 1989). Antioxidants 
can act by; (i) decreasing localized oxygen (O2) concentrations (by combining with or 
displacing O2), (ii) scavenging hydroxyl radicals (OH*) capable of abstracting 
hydrogen atoms and quenching or scavenging singlet oxygen ('O2) which can react 
with lipids to produce peroxides (Di-Mascio et al, 1989), (iii) binding metal ions in 
forms that will not generate reactive species (like OH* , ferryl or Fe^ V Fe"'V O2 
complexes), (iv) removing peroxides by converting them into non radical products 
like aicohols and (v) reacting with propagating radicals (peroxyl or alkoxyl), 
preventing continued hydrogen abstraction from fatty acid side chains. 
Major primary intracellular antioxidants are the enzymes superoxide dismutase, 
catalase and glutathione peroxidase (Ursini and Bindoli, 1987; Touati, 1989; 
Fridovich'', 1989; Sies, 1985; Beyer and Fridovich, 1988; Halliwell and Gutteridge, 
1989). The extracellular fluids of human body, such as blood, seminal plasma, tissue 
cerebrospinal and synovial fluid contain little or no catalase activity and only low 
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activities of superoxide dismutase and selenium containing glutathione peroxidase 
(Thomson, 1985; Blake et al, 1981). Glutathione peroxidase has been purified from 
human plasma and shown to be functionally different from the intracellular enzyme 
(Avissar et al, 1989; Maddipatti and Marnett, 1987; Takahashi et al, 1987). Reduced 
glutathione originates from liver (Meister, 1988) and very little of it is present (2^M) 
in human plasma (Svardal et al, 1990). 
Extracellular superoxide dismutase (SOD) purified by Karlsson and Marklund 
(Karlsson and Marklund" , 1988; Marklund, 1984; Karlsson and Marklund'' , 1988), 
contains copper and zinc but they are very different from intracellular copper and zinc 
superoxide dismutase (Marklund, 1984). Although the biological role of extracellular 
superoxide dismutase is unclear (Halliwell and Gutteridge, 1989; Blake et al, 1981), it 
binds to heparin and in vivo may be associated with endothelial cell surfaces as a 
protective antioxidant over the cells (Karlson and Marklund^ * ' ' , 1988). Removal of 
O2* and H2O2 by SOD, catalase or glutathione peroxidase contributes little to the 
antioxidant activity of extracellular fluids (Halliwell and Gutteridge, 1986). Plasma 
lipoproteins contain a-tocopherol as a major chain breaking antioxidant (Ingold et al, 
1987; Esterbauer et al, 1989). It has been argued by various authors that the major 
antioxidant defence of human plasma involves binding of transition metal ions from 
participating in such reactions (Gutteridge, 1982; Halliwell, 1981; Halliwell and 
Gutteridge, 1986; Gutteridge and Halliwell, 1988; Stocks e/a/, 1974). 
Transferrin present in plasma is loaded with iron and the protein lactoferrin, 
present in human secretions and also released by neutrophils, can act as an antioxidant 
by binding iron ions (Gutteridge and Stocks, 1981; Aruoma and Halliwell, 1987; 
Kvizenga etal, 1987; Britigan etal, 1986). Because hemoglobin can be liberated into 
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plasma and other body fluids afler tissue injury, plasma contains hemoglobin binding 
proteins, haptoglobins, as well as heme binding protein hemopexin. Binding of 
hemoglobin to haptoglobins or of heme to hemopexin diminishes the effectiveness of 
these iron compounds to stimulate oxidative damage. The plasma copper containing 
protein, ceruloplasmin, plays an essential role in iron metabolism, but it also has 
antioxidant properties (Stocks et al, 1974; Gutteridge and Stocks, 1981). 
Ceruloplasmin also binds copper ions non specifically and can thus inhibit copper ion-
stimulated formation of reactive oxidants (e.g. OHf) (Gutteridge , 1984; Lovstad, 
1987). Thus, hemopexin, haptoglobins and ceruloplasmin are important additional 
defences against oxidative damage in the body. 
Albumin can also bind copper ions, and it usually inhibits copper ion-dependent 
lipid peroxidation and OH* radical formation (Gutteridge and Wilkins, 1983; 
Halliwell, 1988; Rowley and Halliwell, 1983). Active oxygen production often 
continues at the site of metal ion binding and damages the protein (Marx and 
Chevion, 1986; Wolff and Dean, 1986), but because of high concentration and rapid 
turnover of albumin in plasma, the damage is probably biologically redundant 
(Halliwell, 1988). Uric acid, bilirubin and biliverdin found in human extracellular 
fluids are known to possess antioxidant activities and are capable of free radical 
scavenging and inhibiting lipid and protein damage (Wolfram et al, 1986; Minetti et 
al, 1998). Also, ascorbic acid present in plasma has multiple antioxidant properties 
(Halliwell and Gutteridge, 1990) including an ability to regenerate a-tocopherol 
radicals at membrane surfaces. Mixtures of ascorbic acid and iron or copper ions have 
powerfiil prooxidant properties (Minotti and Aust, 1987; Aruoma et al, 1989; Ursini 
et al, 1989; Halliwell and Gutteridge, 1985), emphasizing the need for careful 
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sequestration of free transition metal ions in plasma in order for ascorbic acid to exert 
its antioxidant action. 
From the foregoing, it would appear that whereas the intracellular antioxidant 
mechanisms primarily involve radical removing enzymes, the extracellular 
antioxidant systems are dependent on the presence of antioxidant compounds and 
proteins in various fluids. Table! partially summarizes the mode of action of some 
major antioxidants present in human body fluids. 
Pro-oxidant activity of some endogenous metabolites 
Reports published from this laboratory have shown that two of the antioxidant 
molecules given in Tablel (uric acid and bilirubin) also exhibit prooxidant properties 
either alone or in the presence of the metal ions copper and iron. Further, it was also 
demonstrated that L-DOPA, which is the precursor of the neurotransmitter dopamine 
is also capable of DNA cleavage through the generation of the hydroxyl radical. 
These findings are similar to those of several plant derived polyphenolic antioxidants 
such as the flavonoids, tannins, curcuminoids etc which also give rise to reactive 
oxygen species either alone or in the presence of transition metal ions. (Rahman et a/, 
1989; Khan and Hadi, 1998; Ahsan and Hadi, 1998). The major characteristics of 
these reactions are described below. 
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Table 1: ANTIOXIDANTS OF HUMAN BODY FLUIDS (Halliwell 
and Gutteridge, 1990). 
Antioxidant Mode of action Comments 
Heptoglobin/ Hemopexin 
Transferrin 
Binds free hemoglobin/heme. 
Hemoglobin and methemoglobin 
release iron readily on exposure 
to H2O2 or peroxides and can 
accelerate lipd peroxidation; 
binding to heptoglobin/ 
hemopexin hinders tliis. 
Binds iron ions and prevents 
tliem from accelerating free 
radical reactions. 
Acute phase proteins. 
Lactoferrin acts similarly. 
Uric acid Inliibits lipid peroxidation. Ability to bind iron and copper 
ions tightly is an important part of 
its antioxidative role, as is direct 
scavenging of peroxyl, alkoxyl 
radicals and HOCl. 
a-tocopherol 
Glucose 
Lipid soluble antioxidant; breaks 
chain by trapping peroxyl and 
alkoxyl radicals. 
Scavenger of OH* radicals; rate 
constant comparable to that of 
mannitol. 
Most important plasma 
antioxidant. Protects plasma 
lipoproteins against oxidation. 
Nonnal 0asma concentration 
4.5mM. Direct OH* scavenging of 
little physiological significance in 
vivo. 
Bilirubin 
Albumin 
Bile pigment produced by heme 
catabolism. May protect albumin 
bound fatty acids from 
peroxidation. 
Binds free Cu^^ ions and site 
directs any radical damage onto 
albumin molecule itself 
Transports bilirubin. Scavenger 
of HOCl. 
It is also a sensitizer of singlet 
oxygen production. 
Oxidant damaged albumin can be 
rapidly removed from circulation 
and degraded. 
Ceruloplasmin Inliibits iron stimulated OH* 
generation, also lipid 
peroxidation stimulated by iron or 
copper ions. Reacts slowly with 
O2* and H2O2. Ferroxidase 
activity does not result in 
formation of damaging oxygen 
radicals, unlike tlie non-
enzymatic oxidation of Fe^^ 
which gives OH* and otlier 
powerful oxidants. 
Acute phase protein. 
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Uric acid (2,6,8-trioxopurine) is produced in mammalian systems as an end 
product of purine metabolism and has been proposed as a natural physiological 
antioxidant. It is present in human plasma at a relatively high concentrations of upto 
0.6mM. In the presence of Cu(II) and molecular oxygen, uric acid causes breakage of 
calf thymus DNA and supercoiled plasmid DNA. Such breakage is considerably 
enhanced in the presence of visible light. The DNA cleavage does not appear to have 
any preferred 'site(s) or sequence(s) for strand scission. Uric acid catalyses the 
reduction of Cu(II) to Cu(I) which has been shown to be an essential intermediate in 
the DNA cleavage reaction. Uric acid also reduces oxygen to superoxide and 
hydroyyl radicals are formed in the presence of Cu(II). The involvement of active 
oxygen species in the reaction was established by the inhibition of DNA breakage by 
known scavengers of oxygen radicals (Shamsi and Hadi, 1995). Fluorescence 
quenching studies in the presence of DNA indicated that uric acid-DNA complex is 
formed. Uric acid-Cu(II) mediated DNA strand scission is capable of bacteriophage 
inactivation and such inactivation is mediated through reduction of Cu(II) to Cu(I) 
and the generation of oxygen-derived radicals. It is indicated that the DNA breakage 
is repaired in E.coli and involves the repair DNA polymerase (Shamsi et al, 1996). 
Bilirubin is the end product of heme catabolism and has been the subject of 
interest because of its toxicity under conditions of hyperbilirubinemia. Concentrations 
greater than 3 0 0 ^ are associated with the risk of development of neurological 
dysfunctions and several other toxic effects, particularly inhibition of several 
membrane bound enzymes. It has been reported that bilirubin forms a complex with 
Cu(II) and that the formation of the complex results in the reduction of Cu(II) to 
Cu(I). The redox cycling of the metal gives rise to the formation of reactive oxygen 
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species, particularly hydroxyl radicals. The bilirubin-Cu(II) complex causes strand 
breakage in calf thymus DNA and supercoiled plasmid DNA. Cu(I) was shown to be 
an essential intermediate in the DNA cleavage reaction by using the Cu(I) specific 
sequestering reagent neocuproine. Bilirubin-Cu(II) produced hydroxyl radical and the 
involvement of active oxygen species was established by the inhibition of DNA 
breakage by various oxygen radical quenchers (Asad et al, 1999). In order to 
understand the chemical basis of various biological properties of bilirubin, the 
structure-activity relationship between bilirubin and its precursor biliverdin was 
studiea. Bilirubin was found to be more active both as an antioxidant as well as an 
oxidative DNA cleaving agent. In order to account for the enhanced copper reducing 
capacity of bilirubin it was proposed that an additional copper binding site is provided 
for in the case of bilirubin due to the absence of a double bond between pyrrole rings 
II and III. A model for binding of copper to bilirubin was also proposed where two 
copper ions are bound to two molecules of bilirubin through their terminal pyrrole 
nitrogens (Asad et al, 2001). 
L-3,4-Dihydroxyphenylalanine (L-DOPA) is an important metabolite in various 
metabolic reactions. Dopamine, one of the catecholamines, is formed by the 
decarboxylation of L-DOPA which in turn is formed by the hydroxylation of tyrosine. 
In 1994, Halliwell and coworkers (Spencer et al, 1994) had shown that L-DOPA 
causes extensive base modification in DNA in the presence of copper ions. These 
authors further proposed that copper ion release in the presence of L-DOPA and its 
metabolites may be an important mechanism of neurotoxicity eg. in Parkinson's 
disease and Amyotrophic Lateral Sclerosis (ALS). In a subsequent report from this 
laboratory, it was demonstrated that L-DOPA in the presence of Cu(II) alone is 
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capable of causing DNA cleavage through the generation of the hydroxyl radical. 
Further, fluorescence quenching studies indicated that L-DOPA also binds to DNA 
(Shamsi and Hadi, 1995). L-DOPA is the precursor for the synthesis of the pigment 
melanin. It was further shown that melanin is also capable of DNA breakage in the 
presence of copper ions. However, the rate of such strand breakage is considerably 
less than with L-DOPA. Furthermore, the action of L-DOPA and Cu(II) on 
bacteriophage lambda reduces its viability indicating that the reaction is biologically 
active. 
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SCOPE OF THE WORK PRESENTED 
Previous studies have confirmed that antioxidant molecules of plant as well as 
animal origin are themselves capable of acting as prooxidants leading to the 
generation of reactive oxygen species (ROS) particularly in the presence of transition 
metal ions such as copper. These include several classes of plant polyphenolics such 
as flavonoids (Rahman et al, 1989), tannins (Khan and Hadi, 1998), curcuminoids 
(Ahsan and Hadi, 1998) and phytoalexins (Ahmad et al, 2000). Similar properties are 
also exhibited by endogenous molecules of animal origin such as uric acid (Shamsi 
and Hadi, 1995), L-DOPA (Husain and Hadi, 1995) and bilirubin (Asad et al, 1999). 
In the presence of copper ions these molecules generate ROS such as the hydroxyl 
radical which causes base modification and DNA cleavage. In this reaction Cu(II) is 
reduced to Cu(I) and molecular oxygen is required. Copper is an important metal ion 
present in chromatin and is closely associated with DNA bases, particularly guanine 
(Kagawa et al, 1991). Copper has been reported to be neurotoxic as evidenced by the 
brain pathology produced in patients with copper overload as a result of Wilson's 
disease (Hartard et al, 1993). Lipid peroxidation is promoted by copper ions 
(Hochstein et al, 1980; Esterbauer et al, 1989) which also catalyse the formation of 
highly reactive hydroxyl (OH*) radicals from hydrogen peroxide (Halliwell and 
Gutteridge, 1990). Copper ions and H2O2 produce DNA damage, strand breaks 
(Tachon, 1990) and chemical changes in purine and pyrimidine bases, especially 
conversion of guanine into 8-hydroxyguanine (Aruoma et al, 1991). Halliwell and 
coworkers (1994) have shown that L-DOPA, dopamine and 3-o-methyl-DOPA cause 
extensive base modification in DNA in the presence of H2O2 and traces of copper 
ions. These authors propose that the release of copper ions, in the presence of 
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L-DOPA and its metabolites, may be an important mechanism of neurotoxicity as 
observed in Parkinson's disease and ALS. 
An important neurotransmitter in brain and spinal cord is 5-hydroxytryptamine 
or serotonin. Serotonin is involved in the control of sleep and consciousness, 
aggression and mood and is implicated in disturbances such as anxiety and 
depression. Indeed, the structurally related hormone and drug melatonin is currently 
prescribed to regulate sleep disorders. In a recent report it has been shown that copper 
ions are capable of binding to melatonin and serotonin (Limson et al, 1998). It was 
therefore of interest to examine whether serotonin may cause DNA cleavage in the 
presence of copper ions through an oxidative mechanism. In this thesis, the first part 
of the results describe experiments to show that this is indeed the case and that such 
DNA breakage results from the generation of the hydroxyl radical. In order to 
determine the structural features of the serotonin molecule required for the DNA 
cleavage activity, I have also compared the relative DNA cleavage and copper 
binding ability of serotonin with its precursor tryptophan and the related compound 
melatonin (Figure 1). In the second part of the results the mechanism of copper 
binding by serotonin has been examined. These studies have been carried out by 
determining absorption spectral characteristics, copper mediated lipid peroxidation 
and by determining the oxidation of the serotonin molecule. Based on the results a 
model for Cu(II) binding and reduction by serotonin has been proposed. 
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Figure 1: Structures of serotonin, tryptophan and melatonin. 
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MATERIALS 
Chemicals used for the present study were obtained from the following sources: 
Chemicals Sources 
Agar powder 
Agarose 
Bathocuproine disulphate 
Bovine serum albumin 
Catalase 
Deoxyribonucleic acid 
(Calf thymus Type I) 
Diphenylamine 
DL-Tryptophan 
Ethidium bromide 
Ethylenediaminetetraaceticacid 
5-hydroxytryptamine (serotonin) 
Histidine 
L-DOPA 
Mannitol 
N-acetyl-5-methoxytryptamine (melatonin) 
Neocuproine hydrochloride 
Nitroblue tetrazolium 
Nutrient broth 
Hi-Media, India 
Koch Light Laboratories, 
England 
Aldrich Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
BDH, India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
BDH, India 
Sigma Chemical Co., USA 
E Merck, Germany 
Fluka AG, Switzerland 
E Merck, Germany 
Sigma Chemical Co.,USA 
Sigma Chemical Co., USA 
Sisco Research Labs, India 
Hi-Media, India 
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p-Nitroso dimethyl aniline 
Potassium iodide 
Quercetin 
Riboflavin 
Si nuclease 
Sodium azide 
Sodium benzoate 
Supercoiled plasmid pBR322 DNA 
Superoxide dismutase 
T4 DNA 
Thiourea 
Tris (hydroxy methyl) aminomethane HCl 
Triton X-100 
P- Nicotinamide adenine dinucleotide, 
reduced form (NADH) 
Aldrich Chemical Co., USA 
E Merck, Germany 
Sigma Chemical Co., USA 
Sigma Chemical Co.,USA 
Sigma Chemical Co., USA 
E Merck, Germany 
E Merck, Germany 
Isolated and purified in the lab 
according to the procedure of 
Maniatis e/a/, 1982 
Sigma Chemical Co., USA 
Isolated and purified in the lab 
according to the procedure of 
Maniatls etal, 1982 
E Merck, Germany 
Fluka AG, Switzerland 
BDH, India 
Sigma Chemical Co., USA 
All other chemicals were commercial products of analytical grade. 
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Media for E.coliB 
Nutrient Broth (13.0 g/L) obtained from Hi-Media (India) had the following 
components: 
Peptone 5.0 g/L 
NaCl 5.0 g/L 
Beef extract 1.5 g/L 
Yeast extract 1-5 g/L 
pH (approx.) 7.4 ± 0.2 
Nutrient agar (Hard Agar) 
Nutrient Broth 13.0 g/L 
Agar Powder 15.0 g/L 
Soft Agar / Top Agar 
Nutrient Broth 13.0 g/L 
Agar Powder 7,0 g/L 
28 
METHODS 
Serotonin, melatonin, tryptophan and L-DOPA were dissolved in sterilized 
double distilled water as 1-2 mM stock solutions just prior to experimentation. Upon 
addition to reaction mixtures, in the presence of buffers and at the concentrations 
used, all compounds remained in solution. The volumes of stock solution added did 
not lead to any appreciable change in the pH of the reaction mixtures. 
Reaction of serotonin, melatonin, tryptophan and L-DOPA with calf 
thymus DNA and digestion with Si nuclease 
Reaction mixtures (0.5 ml) contained 10 mM Tris-HCl (pH 7.5), 500^g calf 
thymus DNA, serotonin, melatonin, tryptophan, L-DOPA, cupric chloride and other 
metal ions. All solutions were sterilized before use. After incubation at room 
temperature for specified time periods. Si nuclease digestion was performed. The 
assay determines the acid soluble nucleotides released from DNA as a result of 
enzymatic digestion. The reaction mixture in a total volume of 1.0 ml contained 0.1 M 
acetate buffer (pH 4.5), 1 mM zinc sulphate, water and enzyme. The mixture was 
incubated for 2 hours at 42°C. The reaction was stopped by adding 0.2 ml of bovine 
serum albumin (10 mg/ml) and 1.0 ml of 14% perchloric acid (ice cold). The tubes 
were immediately transferred to 0°C for at least 1 hour before centrifugation to 
remove the undigested DNA and precipitated protein. Acid soluble nucleotides were 
determined in the supernatant using the diphenylamine method of Schneider (1957). 
To a 1.0 ml aliquot, 2.0 ml of diphenyl reagent (freshly prepared by dissolving Igm of 
recrystallized diphenylamine in 100 ml of glacial acetic acid and 2.75 ml of 
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conc.H2S04) was added. The tubes were heated in a boiling water bath for 20 
minutes. The intensity of blue colour was read at 600 nm. 
Treatment of supercoiled plasmid pBR322 DNA with serotonin, 
melatonin or tryptophan in the presence of Cu(II) 
Reaction mixtures (30^1) contained 10 mM Tris-HCl (pH 7.5), 0.5 ng of pBR322 
plasmid DNA, and other components as indicated in the legends. Incubation at room 
temperature vvas performed for specified time periods. After incubation, lOjil of a 
solution containing 40 mM EDTA, 0.05% bromophenol blue tracking dye and 50% 
(v/v) glycerol was added and the solution was subjected to electrophoresis in 
submarine 1% agarose gels. The gels were stained with ethidium bromide (0.5 |ig/ml), 
viewed and photographed on a transilluminator. 
Spectrophotometric study for the reduction of Cu(II) to Cu(I) 
The selective Cu(I) sequestering agent bathocuproine or neocuproine was 
employed to detect the reduction of Cu(II) to Cu(I) spectrophotometrically by 
recording the spectra between 300-600 nm using Beckman DU-40 spectrophotometer 
equipped with a plotter. The reaction mixture (1.5 ml) contained 10 mM Tris-HCl (pH 
7.5), 0.06 mM serotonin, melatonin, tryptophan or L-DOPA, 0.04 mM Cu(II) and 
0.1 mM bathocuproine or 0.05 mM neocuproine. The spectra were recorded 
immediately after the addition of Cu(II). 
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Stoichiometric titration of Cu(I) production 
The concentration of Cu(I) produced in the drug-Cu(II) reaction mixture was 
determined by titration with bathocuproine. Bathocuproine complexes with Cu(I) to 
form Cu(bathocuproine)2* complex which has an absorption peak at 480 nm (Nebesar, 
1961). Serotonin (10 and 20 fxM) in 10 mM Tris-HCl (pH 7.5) was mixed with 
varying concentrations of Cu(II) (CuCla) and 0.3 mM bathocuproine, in a total 
volume of 1.5 ml. Absorbance was recorded at 480 nm after adding Cu(II). 
Spectroscopy 
The absorption spectra were obtained by using Beckman DU-40 
spectrophotometer. The fluorescence spectra were recorded on a Shimadzu 
spectrophotometer equipped with a calculator and a plotter. Serotonin was excited at 
its X,maxabs of 280 nm and emission spectra recorded from 300-400 nm. 
Detection of superoxide anion (O2*) 
Superoxide anion was detected by the reduction of nitroblue tetrazolium (NBT) 
essentially as described by Nakayama et al (1983). A typical assay mixture contained 
50 mM potassium phosphate buffer (pH 7.8), 0.033 mM NBT, 0.1 mM EDTA and 
0.06% triton X-100 in a total volume of 3.0 ml. The reaction was started by the 
addition of the compound. After mixing, absorbance was recorded at 560 nm at 
different time intervals against a blank which did not contain the compound. To 
confirm the formation of superoxide anion, superoxide dismutase (SOD) was added to 
the reaction mixture before addition of the compound. 
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Determination of hydroxyl radicals 
Aromatic hydroxylation of salicylate 
This assay is based on the ability of hydroxyl radical to hydroxylate aromatic 
rings at an almost diffusion controlled rate and the measurement of hydroxylated 
products by a simple colorimetric method using salicylate (2-hydroxy benzoate) as a 
detector molecule (Richmond et al, 1981), The reaction mixture (2.0 ml) contained 
the following reagents; 0.1 mM EDTA, 150 mM potassium phosphate buffer (pH 8.0) 
and indicated concentrations of the compounds and Cu(II). The mixture was 
incubated at room temperature for the desired time period. After incubation, the 
reaction was stopped by adding 80^1 of 11.6 M hydrochloric acid and 0.5 g of sodium 
chloride followed by 4.0 ml of chilled diethyl ether. The contents were mixed by 
vortexing for 1 minute. Next, 3.0 ml of the upper ether layer was pipetted out and 
evaporated to dryness in a boiling tube at 40°C. The tubes were cooled and the residue 
dissolved in 0.25 ml of cold distilled water to which the following reagents were 
added in the order stated, (a) 0.125 ml of 10% (w/v) TCA dissolved in 0.5 M HCl, (b) 
0.25 ml of 10% (w/v) sodium tungstate in water and (c) 0.25 ml of 0.5% (w/v) sodium 
nitrite (freshly prepared). After standing for 5 minutes, 0.5 ml of 0.5 M potassium 
hydroxide was added and the absorbance at 510 nm was read exactly after 1 minute. 
Antioxidant properties of serotonin and the structural analogs were assayed by 
their ability to provide protection to calf thymus DNA breakage by hydroxyl radical 
{generated by Fe(II)-EDTA system (Prigodich and Martin, 1990), containing 0.03% 
H2O2, 0.4 mM sodium ascorbate and 0.4 mM Fe(II) - 0.8 mM EDTA}. 
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Singlet oxygen monitoring 
Formation of singlet oxygen (*02) was determined in aqueous solution by the 
method of Kralijic and Mohsini (1978); p-nitrosodimethylaniHne (pRNO) solution 
was prepared in 0.01 M potassium phosphate buffer (pH 7.8). Histidine was added to 
the pRNO solution as a selective accepter of singlet oxygen. Irradiation by fluorescent 
light of the reaction mixture was performed for varying time periods of incubation. 
Singlet oxygen formed a transannular peroxide intermediate complex with histidine, 
leading to the bleaching of pRNO which was then measured spectrophotometrically at 
440 nm. The generation of the singlet oxygen in the reaction system was further 
established by adding sodium azide to the reaction mixture (Joshi, 1985). Singlet 
oxygen generation by riboflavin (Naseem et al, 1993) was used as a positive control. 
Maintenance and growth of bacteria 
The Kcoli strain was streaked on a nutrient agar plate. A single colony was 
picked up from the plate and repurified by streaking. The culture was tested on the 
basis of associated genetic markers; raising it from a single colony on a master plate. 
Having been satisfied with the test clone, the culture was streaked on nutrient agar 
slants. It was then allowed to grow at 37°C and stored at 4°C. The cultures were 
transferred onto fresh slants every month. 
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Preparation of bacteriophage T4 and treatment with serotonin, 
melatonin or tryptophan and Cu(II) 
Bacteriophage stocks were prepared on plates by confluent lysis method 
(Sambrook ei al, 1989). Bacteria from the exponential culture were harvested and 
resuspended in 10 mM MgS04 solution. 0.3 ml of host cells were infected with phage 
at a multiplicity of infection (m.o.i) of 5.0. Adsorption was allowed for 20 minutes at 
37°C and plated with 3.0 ml of molten soft agar on hard agar plates. Plates were then 
incubated at 37°C till confluent lysis was visible to the naked eye. The top agar 
containing the phage was scraped in a 10 mM MgS04 solution, 1% chloroform was 
then added and mixed by gentle vortexing at 37°C. Phage was obtained in the 
supernatant by centrifugation of the above lysate at 10,000 rpm for 20 minutes at 4°C. 
The phage stock thus obtained was titered and stored at 4°C over few drops of 
chloroform. 
For assay of phage inactivation, solutions of serotonin, melatonin or tryptophan 
previously sterilized by filtration, were added to the phage suspension (0.25 ml) in 
Tris-HCl/Mg^* buffer (10 mM each, pH 7.5). The reaction mixture was incubated for 
2 hours at room temperature during which it was vortexed at 5 minute intervals. 
Neocuproine or oxygen free radical quenchers were added before the addition of 
CuCb in some experiments. After incubation, treated phage was diluted with 10 mM 
MgS04 and 0.1 ml of diluted phage was added to a 0.3 ml suspension of E.coli host 
strain. TA-E.COH complexes were vortexed for 1 minute and then incubated for 20 
minutes at 37°C. After incubation, 3.0 ml of soft agar (40°C) was added to the treated 
phage, vortexed and immediately poured on the nutrient agar plates. Plates were 
incubated at 37°C for 5-6 hours followed by counting of plaque forming units (PFU). 
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Preparation of mitochondria 
Mitochondria were isolated in ice cold 150 mM KCl which was used instead of 
sucrose in view of its interference with the measurement of malondialdehyde (Zhang 
and Lindup, 1993). The homogenates (10% w/v) were prepared in a glass 
homogenizer tube (10 ml capacity) with a teflon pestle (FSA laboratories supplies, 
Loughborough, U.K.) for 10 strokes (Black and Decker H501 homogenizer). The 
homogenates were centrifuged at 600g for 5 minutes. The supernatant obtained was 
centrifliged at 12,000g for 10 minutes. The pellets representing the mitochondrial 
fraction were resuspended in 150 mM KCl. All these processes were carried out at 
0-4°C. Protein content was determined by the method of Lowry et al (1951) with 
bovine serum albumin as standard. 
Copper mediated lipid peroxidation of mitochondria 
The reaction mixture in 0.7 ml contained mitochondrial suspension (2 mg 
protein), cupric chloride (50 |aM) and serotonin, melatonin or tryptophan (50 |iM) and 
was incubated for 2 hours at 37°C. The reaction was stopped by the addition of 1.8 ml 
cold distilled water and 1.2 ml of 28% TCA. Following centrifligation at 30,000g for 
10 minutes, 3 ml of supernatant was removed and 0.5 ml of 1% TBA dissolved in 
0.05 N NaOH was added. The tubes were kept in a boiling water bath for 10 minutes 
and the colour formed was read at 530 nm. The TBA reactive material was expressed 
as nanomoles of malondialdehyde (MDA). 
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Nitroblue tetrazolium / glycinate assay for quinones 
Quinones were detected by nitroblue tetrazolium (NBT) reduction (Paz et al, 
1991). A 1 ml solution contained 10 mM potassium phosphate buffer (pH 7.5), 
500 nM serotonin, lOfig catalase and increasing concentrations of cupric chloride 
(CuCb). To generate anaerobic conditions each tube was bubbled with nitrogen for 5 
minutes and sealed with parafilm. Nitrogen was also bubbled through the stock 
solution of cupric chloride which was added at the end and each tube sealed again. 
Catalase was added to remove any hydrogen peroxide. The incubation was done at 
room temperature for 1 hour before adding 1 ml of NBT reagent (0.24 mM NBT and 
2 M glycine, adjusted to pH 10.0 with potassium hydroxide). The mixture was iurther 
incubated at room temperature in dark for 1 hour before reading the absorbance at 
530 nm. 
Protein fragmentation and modification by serotonin, melatonin, 
tryptophan or L-DOPA 
The reaction mixture (1 ml) contained 10 mM potassium phosphate buffer 
(pH 7.4), bovine serum albumin (BSA), CuCU and individual compounds. After 
specified times, the reaction was stopped with EDTA (1 mM) and precipitated with 
trichloroacetic acid (TCA). The generation of material soluble in 5% TCA was 
assessed by measuring the absorbance at 280 nm. 
In order to determine the reducing capacity of the BSA on treatment with the 
above compounds and Cu(II), the pellet obtained after TCA precipitation was fiirther 
washed with 2% TCA before dissolving in 1 ml of 10 mM potassium phosphate 
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buffer (pH 7.4). 200 ^l of this modified protein solution was mixed with neocuproine 
(400 nM) and cupric chloride (100 nM) to a total volume of 3.0 ml in 10 mM 
potassium phosphate buffer (pH 7.4). The copper solution was added at the end and 
the absorbance was read at 450 nm. 
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PART-I 
Strand scission in DNA induced by 
5-hydroxytryptamine (serotonin) in the presence of 
copper ions 
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RESULTS 
Cleavage of plasmid DNA by serotonin and Cu(n) 
DNA cleavage by serotonin and Cu(II) was detected by using supercoiled 
pBR322 DNA, as the relaxation of such a molecule is a sensitive test for just one nick 
per molecule. Serotonin converted supercoiled DNA to relaxed open circles and linear 
forms in a copper dependent reaction and at higher concentrations the molecules were 
converted to progressively smaller heterogenous sized fragments (Figure 2). 
Involvement of Cu(I) in the reaction 
Bathocuproine was employed as a selective Cu(I) sequestering agent to 
determine the reduction of Cu(n) to Cu(I) (Rahman et al, 1989). The Cu(I) chelate of 
bathocuproine has an absorption maximum at 480 nm. It was established that neither 
Cu(II) nor serotonin interfere with this maximum (results not shown) whereas 
serotonin and Cu(II) react to generate Cu(I), indicating the reduction of Cu(II) to 
Cu(I). No reduction of Cu(II) to Cu(I) was seen by melatonin and tryptophan 
(Figure 3). 
Stoichiometry of serotonin-Cu(II) interaction 
To determine the stoichiometry of Cu(II) reduction by serotonin the experiment 
given in Figure 4 was carried out. A Job plot (Moser and Kompf, 1992) of absorbance 
at 480 nm versus Cu(II)/serotonin molar ratio showed the maximum absorbance at a 
molar ratio of 2 at two different concentrations (10 and 20 ^M) of serotonin. This 
implies a 2:1 stoichiometry for the reduction of Cu(II) by free serotonin. The data has 
40 
Figure 2: Agarose gel electrophoretic pattern of ethidium bromide stained 
pBR322 DNA after treatment with increasing concentrations of 
serotonin in the presence of Cu(II). 
The reaction mixture was incubated at room temperature for 1 hour. 
Lane 1: DNA alone; Lane 2-6: 10, 25, 50, 100, 200 i^M serotonin in the 
presence of 100 i^M Cu(II); Lane 7: DNA + Cu(II) (100 ^M). 
1 2 3 ^ 5 6 ? 
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Figure 3: Detection of serotonin, tryptophan and melatonin induced Cu(I) 
production by bathocuproine. 
(••••) : Bathocuproine(100nM)+Cu(lI)(40nM) 
(-•-) : Bathocuproine(100 ^M)+Cu([I)(40^M)+Serotonin(60|j]VO 
(—) : Bathocuproine(100^M)+Cu(Il)(40^M)+Tryptophan(60|JM) 
( " " ) : Bathocuproine(100 nM)+Cu(ir)(40^M)+Melatonin(60 MM) 
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Figure 4: Stoichiometry of serotonin-Cu(n) reduction. 
The concentrations of serotonin used were 10|JM (•) and 20nM (A). 
The difference in absorbance at 480 nm of samples with and without 
added Cu(II) is plotted versus molar equivalents of Cu(II) per molar 
equivalent serotonin. Both curves correspond to 2 equivalents Cu(II) to 
1 equivalent serotonin. 
1.0 1 
Cu(II) / Serotonin 
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also been used to calculate the amount of Cu(I) produced by the two concentrations of 
serotonin (Table 2). As can be seen the production of Cu(I) plateaus at 
Cu(II)/serotonin molar ratio of 2. 
Serotonin-DNA interaction 
When a solution of serotonin is excited at 280 nm, it exhibits a fluorescence 
emission spectrum with a maximum around 330 nm. The addition of DNA to 
serotonin causes a decrease in fluorescence emission and a decreasing degree of 
fluorescence is seen with increasing concentrations of DNA. In the experiment shown 
in Figure 5, the emission spectra of serotonin were recorded using 8 pM serotonin and 
mixtures with 8, 40, 80, 160, 320 and 480 pM bp of calf thymus DNA. 
Serotonin-Cu(II) interaction 
In order to determine whether serotonin also binds copper, the absorption 
spectrum of serotonin was recorded in the presence and absence of Cu(II). Results 
given in Figure 6(a) show that in the presence of 100 ^M Cu(II), an enhancement of 
serotonin absorption peak in the UV region is observed, indicating the binding of 
copper to serotonin. Similar experiments were also done with the structurally related 
compounds; melatonin {Figure 6(b)} and tryptophan {Figure 6(c)}. Only in the case 
of melatonin a slight enhancement of the absorption band is seen, whereas the 
spectrum of tryptophan does not exhibit any difference in the presence of copper. 
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Table 2: Production of Cu(I) from serotonin-Cu(II) interaction as calculated 
from spectrophotometric data of Figure 4. 
Cu(II) added 
(liM) 
0.0 
5.0 
10.0 
20.0 
30.0 
40.0 
50.0 
60.0 
80.0 
100.0 
Cu(I) produced(jiM)" 
lOjiM serotonin 
0.0 
7.5 
12.9 
30.5 
32.2 
34.5 
34.6 
35.5 
35.6 
33.8 
20^M serotonin 
0.0 
6.0 
14.7 
30.5 
43.4 
57.0 
66.8 
70.6 
72.0 
72.7 
^Concentration = (A480(x)- A480(0))/13500, where A480(x)and A480(0) are 
the absorbances at 480nm of the sample with and without Cu(II) and 
13500 is the molar absorptivity of the chromophore. 
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Figure 5: Changes in fluorescence emission of serotonin on addition of calf 
thymus DNA. 
Effect of calf thymus DNA on fluorescence emission (excitation 
wavelength 280 nm) of serotonin. 
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Figure 6: Absorption spectrum of (a) serotonin, (b) melatonin and (c) 
tryptophan in the presence and absence of Cu(II). 
The concentration of serotonin, melatonin and tryptophan was SO^M 
and that of Cu(II) was 100^M. 
(—) in the presence of Cu(II). 
(—) in the absence of Cu(II). 
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Production of hydroxyl radicals by serotonin-Cu(II) complex 
It has been shown that metabolites such as uric acid (Shamsi and Hadi, 1995) 
and L-DOPA (Husain and Hadi, 1998) are able to bind and reduce Cu(II) to Cu(I). 
The reoxidation of Cu(I) by molecular oxygen leads to the formation of reactive 
oxygen species such as the hydroxyl radical. Figure 7 shows that serotonin-Cu(II) 
complex generates hydroxyl radicals as evidenced by aromatic hydroxylation of 
salicylate. In the presence of Cu(II) and with increasing concentrations of serotonin, 
an increasing degree of hydroxyl radical formation is seen. In the absence of Cu(II), 
the hydroxyl radical formation is considerably reduced. The most probable 
mechanism for the formation of the hydroxyl radical is through the formation of 
superoxide anion and consequent generation of hydrogen peroxide. Hydrogen 
peroxide in the presence of Cu(I) gives rise to the hydroxyl radical (Fenton reaction). 
Therefore, the rate of formation of superoxide anion by serotonin, melatonin and 
tryptophan has also been compared (Figure 8). It is seen that serotonin is considerably 
more effective in the generation of the superoxide anion. 
Relative rates of DNA degradation by serotonin, melatonin and 
tryptophan 
In order to explore the chemical basis of the DNA cleavage activity of serotonin-
Cu(II) complex, the relative efficiency of serotonin was compared with the 
structurally related compounds melatonin and tryptophan. Figure 9 shows that when 
all the three metabolites were incubated with plasmid DNA alone, they did not cause 
any conversion to relaxed open circles (lanes 2, 4 and 6). However, when copper was 
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Figure 7: Formation of hydroxyl radicals as a function of serotonin 
concentration. 
The reaction mixtures as described in "Methods" containing increasing 
concentrations of serotonin were incubated for 2 hours at room 
temperature. 
(T) serotonin in the presence of lOOpM Cu(II); (•) in the absence of 
Cu(II). 
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Figure 8: Relative rates of production of superoxide anion (O2*) by 
serotonin, melatonin and tryptophan. 
The reaction mixtures containing serotonin (•), melatonin (A) and 
tryptophan (•) (all 50 nM) were incubated for different time intervals. 
The generation of superoxide anion was carried out as described in 
"Methods". 
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Figure 9: Agarose gel electrophoretic pattern of pBR322 DNA after 
treatment with serotonin, melatonin and tryptophan in the 
presence of Cu(n). 
The concentration of serotonin, melatonin, tryptophan and Cu(II) was 
lOOfiM in all the cases. The reaction mixture was incubated at room 
temperature for 2 hours. 
Lane 1: DNA alone; Lane 2: DNA + serotonin; Lane 3: DNA + 
serotonin + Cu(II); Lane 4; DNA + melatonin; Lane 5: DNA + 
melatonin + Cu(II); Lane 6: DNA + tryptophan; Lane 7: DNA + 
tryptophan + Cu(II). 
1 2 3 4 5 6 
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included in the reaction, full conversion to the open circular form was seen with 
serotonin only (lane 3), whereas some conversion was also observed in the case of 
melatonin (lane 5). However, tryptophan did not cause any change from the 
supercoiled to the relaxed form (lane 7). These results were further confirmed by the 
assay using Si nuclease hydrolysis, where the DNA degradation can be easily 
quantitated. Serotonin-Cu(II) generates Si sensitive sites in calf thymus DNA and the 
reaction is assessed by recording the proportion of double stranded DNA converted to 
acid soluble nucleotides by Si nuclease. The results shown in Table 3 compare the 
DNA hydrolysis by L-DOPA, serotonin, melatonin and tryptophan. The largest extent 
of hydrolysis is seen in the case of L-DOPA, followed by serotonin, whereas 
melatonin and tryptophan do not show any activity. 
Involvement of active oxygen species in DNA cleavage by serotonin-
Cu(Il) 
The serotonin-Cu(II) mediated DNA breakage reaction was tested for inhibition 
by various oxygen radical scavengers. Superoxide dismutase (SOD) and catalase 
remove superoxide anion and H2O2 respectively. Thiourea and potassium iodide are 
quenchers of hydroxy! radicals whereas sodium azide removes singlet oxygen. As 
seen in Figure 10, only catalase and thiourea cause significant inhibition of the 
conversion of supercoiled to the open circular form indicating that hydrogen peroxide 
and hydroxyl radical are involved in the mechanism of DNA cleavage by serotonin 
and Cu(II). 
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Table 3: Degradation of calf thymus DNA by L-DOPA, serotonin, melatonin 
and tryptophan in the presence of Cu(II) as measured by the degree of 
Si nuclease digestion. 
Reaction 
DNA + Cu(II) + L-DOPA 
DNA + Cu(II) + Serotonin 
DNA + Cu(II) + Melatonin 
DNA + Cu(II) + Tryptophan 
% DNA hydrolysed 
4.84 
2.16 
0.00 
0.00 
DNA was incubated with the four compounds (all 200 ^M) in the 
presence of Cu(II) (200 fxM) at room temperature for 2 hours. Si 
nuclease digestion and determination of acid soluble material was 
done as described in "Methods". 
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Figure 10: Inhibition of pBR 322 plasmid DNA degradation after treatment 
with serotonin and Cu(n) in the presence of scavengers. 
Reaction mixtures contained serotonin and Cu(II) (both lOO i^M), in the 
presence of different scavengers. Incubation was performed at room 
temperature for 2 hours. 
Lane 1: DNA alone; Lane 2: DNA + serotonin + Cu(II); Lane 3-7: 
superoxide dismutase (100 pg/ml), catalase (100 pg/ml), sodium azide 
(50 mM), thiourea (50 mM), potassium iodide (50 mM) respectively in 
the presence of serotonin and Cu(II). 
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Enhancement of serotonin-Cu(II) mediated DNA strand breaks by 
NADH 
It has been reported that NADH or NADPH promote the redox cycling of 
compounds such as hydroquinones (Hiraku ei al, 1995) and catecholestrogens 
(Thibodeau and Paquette, 1999). Such redox cycling in the presence of metal ions 
such as copper is capable of causing strand breaks in DNA through the generation of 
reactive oxygen species. It was therefore of interest to examine the effect of NADH 
on serotonin-Cu(II) mediated DNA cleavage. Figure 11 shows an experiment where 
the effect of increasing serotonin concentrations on plasmid DNA cleavage in the 
absence and presence of NADH has been examined. The results show that whereas all 
the three concentrations of serotonin do not lead to complete conversion of 
supercoiled to relaxed form, the presence of NADH causes the complete 
disappearance of the supercoiled molecules. Thus, in the presence of NADH the rate 
of DNA cleavage is increased. These results suggest that possibly NADH causes the 
redox cycling of serotonin by reducing the oxidised form of the metabolite produced 
by reduction of Cu(II). Similar results showing a higher rate of DNA breakage with 
NADH are also obtained with the Si nuclease assay where calf thymus DNA is used 
as the substrate (Figure 12). Figure 13 compares the effect of NADH with hydrogen 
peroxide on DNA cleavage by serotonin-Cu(II). Under the conditions used the 
combination of Cu(II) and NADH leads to some conversion to the relaxed form of 
plasmid (lane 3). However, this effect is considerably enhanced by further addition of 
serotonin (lane 4). In the presence of Cu(II) and hydrogen peroxide or Cu(II), 
hydrogen peroxide and serotonin complete hydrolysis of plasmid DNA to nucleotides 
or oligonucleotides was seen (lanes 5 and 6). Thus, both NADH and H2O2 have 
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Figure 11: Effect of NADH on serotonin-Cu(n) mediated cleavage of pBR322 
plasmid DNA. 
The concentration of Cu(II) was 200 |jM in all the samples. The 
reaction mixture was incubated at room temperature for 2 hours. 
Lane 1; DNA alone; Lane 2-4: 50, 100 and 200 pM serotonin 
respectively; Lane 5: serotonin (50 pM) + NADH (200 pM); Lane 6: 
serotonin (100 pM) + NADH (200 pM); Lane 7: serotonin (200 pM) + 
NADH (200 pM). 
oc 
sc 
56 
Figure 12: Kinetics of serotonin-Cu(n) mediated degradation of calf thymus 
DNA in the presence and absence of NADH. 
(A) in the presence of NADH. 
(•) in the absence of NADH. 
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Figure 13: Effect of NADH and H2O2 on serotonin-Cu(II) mediated cleavage 
of pBR322 plasmid DNA. 
The reaction mixture was incubated at room temperature for 2 hours. 
Lane 1: DNA alone; Lane 2: DNA + serotonin (200[M); Lane 3: DNA 
+ Cu(II) (200 nM) + NADH (200 pM); Lane 4: same as lane 3 + 
serotonin (200 MM); Lane 5: DNA + Cu(II) (200 i^M) + H2O2 (0.03%); 
Lane 6 : same as lane 5 + serotonin (200 jiM). 
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similar effect although the mechanisms could be different. Whereas the NADH 
possibly acts to reduce oxidised serotonin, H2O2 acts on reduced copper to enhance 
the generation of the hydroxyl radical (Fenton reaction). 
Effect of serotonin-Cu(II) on the viability of bacteriophage T4 
In order to explore the biological consequences of the DNA breakage reaction, 
the inactivation of phage T4 by the serotonin-Cu(II) system was tested. The 
inactivating activity was determined by incubating the phage with serotonin-Cu(II) 
and then measuring the loss of phage viability. Figure 14 gives the % survival of 
phage as a function of the serotonin concentration. In Table 4 is given a comparison 
of serotonin, melatonin and tryptophan in a similar experiment. Surprisingly, 
melatonin and tryptophan also caused phage inactivation and to a greater extent than 
serotonin. 
The serotonin-Cu(II) phage inactivation was found to be inhibited by various 
radical scavengers. The results are given in Table 5 as % survival of control in the 
presence of various quenchers. The maximum survival is seen in the presence of 
neocuproine, which is consistent with Cu(I) being an essential intermediate in the 
reaction. This is followed by thiourea and sodium benzoate which are effective 
quenchers of the hydroxyl radical. Catalase and sodium azide, scavengers of hydrogen 
peroxide and singlet oxygen are also effective inhibitors of phage inactivation. From 
the data it could be suggested that H2O2 is an essential component in a pathway that 
leads to reactive oxygen species, of which superoxide anion and singlet oxygen are 
alternate DNA cleaving agents. 
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Figure 14: Effect of increasing concentrations of serotonin on the viability of 
bacteriophage T4 treated in the presence of Cu(II). 
The concentration of Cu(II) was 200 \iM. All the points represent 
triplicate samples and mean values have been plotted. 
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Sensitivity of bacteriophage T4 to serotonin, melatonin and tryptophan 
in the presence of Cu(II). 
Phage treatment 
Control 
Serotonin 
Melatonin 
Tryptophan 
PFU/ml 
1.3X10^ 
3.3 X 10^ 
1.5x10^ 
2.05 x 10* 
% Survival 
100.00 
25.38 
11.53 
15.76 
The concentration of serotonin, melatonin, tryptophan and Cu(II) was 
200|iM. The host strain used was E.coli B. The incubation of phage 
suspension with copper and the compounds was carried out for 2 hours 
at room temperature. 
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Table 5: Effect of oxygen radical quenchers on the viability of bacteriophage T4 
after treatment with serotonin in the presence of Cu(II). 
Phage treatment 
Control 
Serotonin + Cu(II) 
Serotonin + Cu(II) + Thiourea (50mM) 
Serotonin + Cu(II) + Sodium azide (50mM) 
Serotonin + Cu(II) + Catalase (5mg/ml) 
Serotonin + Cu(II) + Neocuproine (300^M) 
Serotonin + Cu(II) + Sodium benzoate (50mM) 
PFU/ml 
3.25 X 10^  
4.80X 10' 
2.82X10^ 
1.74x10^ 
2.10x10^ 
3.10X10^ 
2.46 X 10^ 
% Survival 
100.00 
14.76 
86.76 
53.52 
64.50 
95.38 
75.69 
The concentration of serotonin and Cu(II) was 200 ^M and 100 \xM 
respectively. 
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Fragmentation and modification of BSA by serotonin-Cu(II) 
Free radicals such as the hydroxyl radical have been shown to fragment and 
crosslink proteins (Wolff and Dean, 1986). Since proteins are present inside and 
outside cells in high concentrations, modification by free radicals may have amplified 
effects on these critical targets. The fragmentation of BSA was examined by serotonin 
and the related metabolites in the presence of Cu(II). Figure 15 shows that increasing 
concentrations of L-DOPA, with a fixed concentration of Cu(II) (100 \xM) leads to an 
increase in the formation of acid soluble material. In Table 6, BSA fragmentation by 
L-DOPA is compared with serotonin, melatonin and tryptophan. As seen, in addition 
to L-DOPA only serotonin was found to degrade BSA. 
In addition to protein fragmentation, a major product of hydroxyl radical 
reaction with proteins is 3,4-dihydroxyphenylalanine (DOPA) which has the property 
of reducing cytochrome c, free iron and copper ions (Gieseg et al, 1993). It has been 
shown that hydroxyl radical damaged proteins contain significant amounts of protein 
bound DOPA (PB-DOPA) (Figure 16). It was therefore of interest to determine 
whether the serotonin-Cu(II) reaction with BSA leads to the formation of PB-DOPA. 
As described in "Methods", the treated BSA was acid precipitated, washed and 
dissolved in phosphate buffer and used to examine whether Cu(II) is reduced to Cu(I). 
Figure 17 gives the effect of increasing concentrations of L-DOPA on the formation 
of neocuproine-Cu(I) complex indicating an increasing level of Cu(II) reduction. 
Table 7 compares the relative activity of L-DOPA, serotonin, melatonin and 
tryptophan in the presence of Cu(II). L-DOPA generates the largest extent of Cu(II) 
reducing capacity in BSA followed by serotonin, tryptophan and melatonin. 
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Figure 15: Degradation of protein (BSA) with increasing L-DOPA 
concentration in the presence of Cu(n). 
The concentration of Cu(II) and BSA was 100 (iM and 2mg/ml 
respectively. 
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Table 6: Degradation of bovine serum albumin (BSA) by L-DOPA, serotonin, 
melatonin and tryptophan in the presence of Cu(II). 
Treatment 
BSA + L-DOPA+ Cu(II) 
BSA + Serotonin + Cu(II) 
BSA + Melatonin + Cu(II) 
BSA + Tryptophan + Cu(II) 
Absorbance at 280nm 
0.13 
0.05 
0.00 
0.00 
The concentration of L-DOPA, serotonin, melatonin and tryptophan 
was 200^M and that of Cu(II) was lOOjiM. 
The degradation of BSA was measured by recording the absorption at 
280nm of the TCA soluble material. Since all the compounds alone 
absorb in the UV region, control reactions were also run in the 
presence of compounds alone and the absorbance at 280nm was 
substracted from the experimental reactions [compound + Cu(II)]. The 
incubation was carried out for 2 hours at room temperature. 
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Figure 16: Structure of protein-bound 3,4 - dihydroxyphenylalanine. 
R' 
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Figure 17: Modification of BSA with increasing concentrationsof L-DOPA in 
the presence of Cu(II) as measured by the reducing capacity of the 
modified protein. 
The concentration of Cu(II) and BSA was 100 |aM and 2mg/ml 
respectively. Detailed procedure is given in "Methods". 
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Table 7: Modification of bovine semm albumin (BSA) by serotonin, melatonin, 
tryptophan and L-DOPA in the presence of Cu(II) and determination 
of the reducing capacity of the modified BSA. 
Treatment 
BSA + Cu(II) 
BSA + Cu(II)+ Serotonin 
BSA + Cu(II) + Melatonin 
BSA + Cu(II)+ Tryptophan 
BSA+ Cu(II) +L-DOPA 
Absorbance at 480nm 
0.013 
0.041 
0.009 
0.027 
0.081 
The concentration of serotonin, melatonin, tryptophan and L-DOPA 
was 200^lM and that of Cu(II) was lOO^M. 
The reducing capacity of modified BSA was determined by its ability 
to reduce Cu(II) and the formation of (bathocuproine)2-Cu(I) complex 
which absorbs at 480nm. The details of the procedure are given in 
"Methods". 
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Antioxidant activity of serotonin, melatonin and tryptophan on the 
generation of the hydroxyl radical and singlet oxygen 
As discussed in "Introduction", many metabolites are considered to have 
antioxidant functions. In particular melatonin has been shown to posses antioxidant 
properties (Zhang et al, 1998). It was therefore considered to be of interest to compare 
the hydroxyl radical and singlet oxygen quenching effect of the three metabolites. 
Table 8 shows the effect of serotonin, melatonin and tryptophan on the formation of 
the hydroxyl radical generated through the Fe(II)-EDTA system in the presence of 
H2O2 and ascorbate (Prigodich and Martin, 1990). Thiourea was used as a positive 
control. As can be seen the formation of hydroxyl radicals is inhibited to about 
25-33% by the three metabolites with serotonin being a more effective quencher. 
Thiourea as expected shows about 90% inhibition. 
The production of singlet oxygen by riboflavin (a known photosensitiser and 
generator of singlet oxygen) and its inhibition by the three metabolites was studied by 
recording the decrease in the absorption of pRNO solution. Sodium azide, a known 
scavenger of singlet oxygen was used as a positive control. As is seen in Figure 18 all 
the three metabolites showed inhibition of singlet oxygen generation to variable 
degrees with serotonin inhibiting to a greater extent. 
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Table 8: Effect of serotonin, melatonin and tryptophan on hydroxyl radical 
generation by Fe(II)-EDTA system. 
Compound 
Control 
Serotonin (200jiM) 
Melatonin (200jiM) 
Tryptophan (200\iM) 
Thiourea (200nM) 
Absorbance at 532 nm 
0.351 
0.233 
0.270 
0.260 
0.041 
% inhibition 
— 
33.62 
23.08 
25.93 
88.32 
Details of the procedure are given in "Methods". The procedure 
measures the protection by the compounds tested to calf thymus DNA 
breakage by the hydroxyl radical. 
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DISCUSSION 
The principal conclusions of the above experiments may be stated as follows 
(i) As in the case of L-DOPA, the neurotransmitter serotonin also is capable of 
causing DNA cleavage in the presence of Cu(II); (ii) This property of serotonin can be 
almost entirely attributed to the phenolic group present. This is evidenced by the fact 
that the methoxylation of the phenolic group in melatonin almost completely 
abolishes the DNA cleavage activity. 
DNA damage by hydroxyl radicals is well established (Pryor, 1988) and the 
present resuhs indicate a similar mechanism of DNA cleavage by serotonin-Cu(II) 
system. The hydroxyl radicals are possibly generated through the Fenton reaction 
which would use hydrogen peroxide and Cu(I) to produce the radical. A number of 
molecules present in human extracellular fluids are considered to have antioxidant 
function and these include ascorbic acid and uric acid. Production of hydroxyl radical 
and DNA damage by ascorbate and H2O2 in the presence of Cu(II) has been reported 
(Rowly and Halliwell, 1983; Stoewe and Perutz, 1987). It has been shown that uric 
acid in the presence of Cu(II) alone is capable of causing strand scission in DNA and 
that this reaction is associated with the generation of ROS (Shamsi and Hadi, 1995). It 
has therefore been suggested that several of the biological antioxidants are themselves 
capabl*", of generating ROS under appropriate conditions. In the light of the work of 
Halliwell and coworkers (Spencer et al, 1994) the present results further emphasize 
the putative role in vivo of serotonin and copper ions as a source of oxidative DNA 
damage. It is recognised by most workers that hydroxyl radical reactions with DNA 
are preceded by the association of a complex with DNA, followed by the production 
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of hydroxyl radicals at that particular site (Pryor, 1988). As shown above, serotonin is 
capable of binding to DNA and if copper ions are available a ternary complex of 
serotonin-Cu(II)-DNA may be formed as in the case of several other ROS generating 
and DNA cleavage systems (Rahman et al, 1989; Wong et al, 1984). It may be of 
interest to note that Halliwell and coworkers (Spencer et al, 1994) have shown that 
copper ion concentration in human brain tissue damaged in Parkinson's disease are at 
a level that could promote oxidative DNA damage. 
Progressive accumulation of genetic mutations is thought to be central to the 
forces of tumorigenesis and aging (Fearon and Vogelstein, 1990). Most of the critical 
genes that are mutated during the development of human cancer can be broadly 
classified as either protooncogenes or tumor suppressor genes (Weinberg, 1989). 
Althoi'gh their activity can be altered by a broad range of mutational events, in many 
cases single basepair substitutions are sufficient to activate protooncogenes or 
inactivate tumor suppressor genes. The question arises as to what causes the base-pair 
substitutions that amass in multiple cellular genes during neoplastic transformation 
and aging? Replication errors, spontaneous deamination and depurination and DNA 
damage induced by exposure to exogenous chemicals are all likely possibilities. 
However, there is growing realization that adducts are also produced from 
endogenous chemicals that arise during normal metabolism, oxidative stress and 
chronic inflammation inter alia (Ames and Gold, 1991). If DNA adducts from 
endogenous chemicals possess similar mutagenic potential to those from exogenous 
chemicals, these adducts may also contribute to the etiology of genetic disease and 
therein the base line of human cancer. The adducts considered include oxidised bases, 
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alkylated bases, exocyclic base adducts and a series of unidentified putative adducts 
called I-compounds. 
Finally the data using BSA as the substrate confirm that the free radicals 
generated by serotonin or related metabolites and Cu(II) are also capable of 
fragmenting proteins. The relative degree of fragmentation by the four metabolites 
namely L-DOPA, serotonin, melatonin and tryptophan is similar to that observed in 
the case of DNA breakage. Also the extent of Cu(n) reduction by modified BSA is 
along similar lines where L-DOPA-Cu(II) modified BSA was the most effective 
followed by serotonin, tryptophan and melatonin. These results would suggest that the 
mechanism of protein fragmentation by serotonin-Cu(II) is the same which operates 
in the case of DNA breakage. Further, bacteriophage inactivation by serotonin-Cu(lI) 
system indicates that the DNA strand scission / protein fragmentation reaction is 
biologically active. 
PART-II 
Mechanism of copper binding by serotonin 
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RESULTS 
Interaction of various metal ions with serotonin 
As already shown in the previous section serotonin causes strand scission in 
DNA in the presence of copper ions. Table 9 compares the Si nuclease hydrolysis of 
calf thymus DNA treated with serotonin in the presence of different metal ions. Of the 
several metal ions tested, only Cu(II) and Fe(II) complement serotonin in the DNA 
breakage reaction. Of these, Cu(II) was found to be more effective. The interaction of 
different metal ions with serotonin was further studied by recording the UV-
absorption spectrum of serotonin in the presence of different metals. Resuhs given in 
Figure 19 show that on addition of Cu(II) and Fe(II) an enhancement of the serotonin 
absorption band is observed indicating an interaction of these ions with the 
neurotransmitter. The addition of other metals (Ni, Mn, Mg and Co) did not have any 
effect on the absorption spectrum. The interaction of these two metals [Cu(II) and 
Fe(n)] was also studied as a function of pH. In Figure 20 is shown the effect of 
addition of copper at pH 3.7, 7.5 and 10.0. It is seen that only at pH 7.5 an 
enhancement in the absorption band at 275 nm is observed. A similar experiment was 
also done in the presence of Fe(II) (Figure 21). In this case also the enhancement 
effect on the absorption at 275 nm of serotonin is observed only at pH 7.5. At other 
pH values of 3.7 and 10.0 a broadening of the absorption band is seen possibly 
suggesting the existence of a variety of serotonin-Fe(II) complexes. An experiment 
was also carried out to determine whether copper can be mobilized by another 
chelating agent such as quercetin. Quercetin is a plant derived polyphenol which 
binds copper giving rise to a charge transfer complex which absorbs at 430 nm 
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Table 9: Si nuclease hydrolysis of calf thymus DNA treated with serotonin in 
the presence of different metal ions. 
Metal ion 
Serotonin alone 
Serotonin + Cu(II) 
Serotonin + Fe(II) 
Serotonin + Mg(II) 
Serotonin + Co(II) 
Serotonin + Mn(II) 
Serotonin + Ni(II) 
% DNA hydrolyzed 
0.00 
7.80 
2.34 
0.00 
0.00 
0.00 
0.00 
Reaction conditions were as described in "Methods". The 
concentration of serotonin and the various metal ions was 200 |jM and 
100 nM respectively. 
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Figure 19: Absorption spectrum of serotonin in the presence of different 
metal ions. 
The absorption solution contained 50 nM serotonin and 100 jxM metal 
ions in 10 mM Tris-HCl (pH 7.5). 
Trace 1 is serotonin alone and traces 2-7 are with Cu^^ Fe*^ Mn^^ 
Ni"^ ,^ Mg^^ , and Co^ ^ ions respectively. 
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Figure 20 (A): Absorption spectrum of serotonin in the presence of Cu(II) at 
pH 3.7. 
The concentration of serotonin and Cu(II) was 50 ^M and 
100 \iM respectively. 
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Figure 20 (B): Absorption spectrum of serotonin in the presence of Cu(II) at 
pH 7.5. 
The concentration of serotonin and Cu(II) was 50 |iM and 
100 i^M respectively. 
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Figure 20 (C): Absorption spectrum of serotonin in the presence of Cu(II) at 
pH 10.0. 
The concentration of serotonin and Cu(II) was 50 |aM and 
100 |iM respectively. 
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Figure 21 (A): Absorption spectrum of serotonin in the presence of Fe(II) at 
pH 3.7. 
The concentration of serotonin and Cu(II) was 50 |aM and 
100 laM respectively. 
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Figure 21 (B): Absorption spectrum of serotonin in the presence of Fe(II) at 
pH 7.5. 
The concentration of serotonin and Cu(II) was 50 |j.M and 
100 (iM respectively. 
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Figure 21 (C): Absorption spectrum of serotonin in the presence of Fe(n) at 
pH 10.0. 
The concentration of serotonin and Cu(n) was 50 (iM and 
100 nM respectively. 
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(Rahman et al, 1990). The results given in Figure 22 show that when quercetin is 
added to the serotonin-Cu(II) complex the charge transfer complex of quercetin-
Cu(II) is generated. These results indicate that quercetin is able to mobilize copper 
from serotonin-Cu(II) complex. Figure 23 shows the effect of increasing 
concentrations of Cu(II) on the UV-absorption spectrum of serotonin. In addition to 
the enhancement in the absorption band, a shift towards lower wavelength is also 
observed which is indicative of the formation of an oxidised species of serotonin. 
Interaction of structurally related compounds melatonin and 
tryptophan with Cu(II) 
It was previously reported (Hadi et al, 2001) that serotonin reduces Cu(II) to 
generate Cu(I) as evidenced by the formation of a complex in the presence of 
bathocuproine {a copper (I) specific sequestering agent} absorbing at 480 nm. In 
order to examine the chemical basis of the binding of copper to serotonin, the 
complex formation was also determined with the structurally related metabolites 
tryptophan and melatonin. As seen in Figure 3 only serotonin is capable of reducing 
Cu(II) to Cu(I) to a significant extent. This was further investigated by studying the 
effect of serotonin, melatonin and tryptophan on copper mediated lipid peroxidation 
in rat brain mitochondria. It was first shown that copper is able to catalyse the lipid 
peroxidation in rat brain homogenates (Figure 24) as has been reported earlier 
(Boehme et al, 1977). Copper is also known to catalyse the peroxidation of 
mitochondrial membranes to generate malondialdehyde which reacts with 
thiobarbituric acid to form a colored complex absorbing at 532 nm (Zhang and 
Lindup, 1993). As seen in Table 10, only serotonin is capable of completely 
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Figure 22: Effect of quercetin on absorption spectrum of $erotonin-Cu(I]) 
complex. 
The concentration of quercetin, serotonin and Cu(II) was 25 i^M, 
50 nM and 100 ^M respectively. 
) : serotonin alone. 
- • • - ) : serotonin + Cu (II). 
• • • •) : quercetin alone. 
— ) : quercetin + Cu(II) 
- X - -) : serotonin + Cu(II) + quercetin. 
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Figure 23: Effect of increasing concentrations of Cu(II) on the absorption 
spectrum of serotonin. 
The concentration of serotonin was 50 ^M in lOmM Tris-HCl (pH7.5). 
(—): serotonin alone 
(-•-) : serotonin + 50 ^M Cu(II) 
( — ) : serotonin + 100 ^M Cu(II) 
(••••): serotonin + 200 ^M Cu(II). 
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Figure 24; Effect of increasing concentrations of copper on lipid peroxidation 
in rat brain homogenate. 
Detailed procedure is given in "Methods". 
Cu(Il) (|iM) 
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abolishing the formation of TBA reactive material, presumably by sequestering 
copper ions. These results and those of the previous section are indicative of the 
involvement of the phenolic group in serotonin for binding copper ions. 
Copper catalysed quinone formation by serotonin 
The formation of quinone by the interaction of serotonin with copper ions was 
detected by the nitroblue tetrazolium/glycinate assay for quinones described by Paz et 
al (1991). In order to eliminate the possibility of interference by superoxide (which 
may lead to the production of hydrogen peroxide) the reaction was carried out under 
anaerobic conditions and in the presence of catalase. The results given in Figure 25 
show that with an increasing concentration of copper ions an increased degree of 
nitroblue tetrazolium reduction is seen which is indicative of quinone formation as a 
resuh of copper mediated oxidation of serotonin (Gieseg et al, 1993). 
89 
Table 10; Effect of serotonin, melatonin and tryptophan on copper mediated lipid 
peroxidation in rat brain mitochondria. 
Treatment 
Mitochondria alone 
Mitochondria + Cu(II) 
Mitochondria + Cu(II) + Serotonin 
Mitochondria + Cu(II) + Melatonin 
Mitochondria + Cu(II) + Tryptophan 
nmoles of MDA formed 
1.20 
6.44 
1.22 
6.25 
6.50 
Reaction conditions were as described in "Methods". The 
concentration of Cu(II), serotonin, melatonin and tryptophan was 
50 nM. 
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Figure 25: Quinone formation by serotonin as a function of Cu(II) 
concentration. 
The concentration of serotonin was SO^M. 
( • ) In the presence of serotonin 
(•) In the absence of serotonin. 
0.12 n 
0.00 • 
Cu(II) (^M) 
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DISCUSSION 
The present studies lead to the following major conclusions: 
1. Of the various metal ions tested only Cu(II) and Fe(II) complement serotonin 
in the DNA cleavage reaction. Further, only Cu(II) and Fe(II) interact and bind 
to serotonin. 
2. Experiments with structurally related compounds melatonin and tryptophan 
indicate that the interaction of serotonin with Cu(II) involves the phenolic 
group and that such interaction results in the oxidation of serotonin giving rise 
to a quinone methide. 
Based on the above results, we propose a possible model for Cu(II) binding 
to serotonin resulting in the reduction of Cu(II) and oxidation of serotonin (Figure 
26). According to this model serotonin can reduce 2 molar equivalents of Cu(II) to 
Cu(I) through a reaction involving two electron oxidation of the phenol to a 
quinone methide. This is in concurrence with the results of Job plot which showed 
a stoichiometry of Cu(II) reduction of 2 by serotonin (Hadi et al, 2001). 
The metabolic precursor of serotonin is 5-hydroxytryptophan, which in turn 
is formed by hydroxylation of tryptophan. Serotonin is further metabolised to give 
rise to melatonin by N-acetylation followed by methylation of the 5-hydroxy 
group in the pineal gland. Melatonin is a hormone and is considered to regulate 
sleep cycle. Another neurotransmitter which has been shown to cause DNA 
damage and DNA base modification in the presence of hydrogen peroxide and 
copper ions is dopamine (Spencer et al, 1994). Dopamine is formed by the 
decarboxylation of L-DOPA, which in turn is formed by the hydroxylation of 
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tyrosine. Previous work has shown that L-DOPA in the presence of Cu(II) alone 
can cause DNA cleavage through the generation of the hydroxyl radical (Husain 
and Hadi, 1995). It is recognised by most workers that hydroxyl radical reactions 
with DNA are preceded by the association of a complex with DNA, followed by 
the production of hydroxyl radicals at that site (Pryor, 1988). As shown in the 
previous section (Hadi et al, 2001), serotonin is capable of binding to DNA and 
since copper is an essential component of chromatin (Burkitt et al, 1996) a ternary 
complex of serotonin-Cu(II)-DNA may be formed as in the case of several other 
ROS generating and DNA cleavage systems (Rahman et al, 1989 and Wong et al, 
1984). Thus, a number of molecules in the nervous system and their precursors are 
capable of oxidative DNA damage in the presence of copper ions. The 
concentrations of serotonin necessary for DNA cleavage (10|aM and above) (Hadi 
et al, 2001) do not approach the in vivo levels (0.2 - 1.14(j,M in blood). However, 
it is conceivable that the cumulative effect of such endogenous metabolites could 
be of physiological significance and could contribute to the etiology of genetic 
disease. Further, it has been proposed by Halliwell and coworkers (Spencer et al, 
1994) that copper ion concentrations in human brain tissue damaged in 
Parkinson's (Spencer et al, 1994) and Wilson's diseases (Hartard et al, 1993) are 
at a level that can promote oxidative DNA damage. 
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Abstract 
It has been proposed that considerable DNA damage may be caused by endogenous metabolites produced dur ing the 
body's normal metabolic processes Several metabolites including L-3,4-dihydroxyphenylalanine and dopamine have 
been previously shown to lead to oxidative DNA breakage in the presence of copper ions 5-hydroxytryptamine or 
serotonin is an important neurotransmitter in brain and spinal cord and is involved in the control of sleep and conscious 
ness, aggression and mood In this paper we show that serotonin is also capable of causing strand cleavage in DNA in 
the presence of Cu(ll) through an oxidative mechanism Serotonin reduces Cu(ll) to Cu(l) which is accompanied by the 
generation of hydroxyl radical Spectroscopic data indicate that serotonin is able to bind to DNA and copper ions 
Relative DNA cleavage efficiency and copper binding abil ity of serotonin and structurally related molecules tryptophan 
and melatonin indicates that the phenolic group in serotonin is required for strand cleavage activity © 2001 Elsevier 
Science Ireland Ltd All rights reserved 
Keywords Endogenous DNA damage, Serotonin, Cu(ll) reduction, Hydroxyl radical 
It has been pioposed that consideiabie DNA damage may 
be caused by endogenous metdbolites produced during the 
body's normal metabolic piocesses For example, it has been 
shown that malondialdehyde which is the ubiquitous product 
of lipid peroxidation and eicosanoid metabolism reacts with 
cellular DNA to form a propanodeoxy-guanosine adduct [3] 
Evidence indicates that the adduct exists at significant levels 
in the hepatic DNA of rats and humans and is an efficient 
premutagenic lesion in E colt [2] Dopamine, formed by the 
decarboxylation of L-3,4-dihydroxyphenylalanine (L-
DOPA), condenses with acetaldehyde a pioduct of ethanol 
metabolism, to generate l-methyl-6,7-dihydroxy-1,2,3,4 
tetra hydroisoquinoline (Salsolinol) [4] Salsolinol is consid-
ered to be involved m the etiology of Parkinson's and 
Huntington's diseases and has been detected in the cere-
brospinal fluid of Parkinsonian patients [12] It has also 
been shown to cause strand breakage in DNA and cell 
death in the piesence of copper ions [9] Thus, there is grow-
ing evidence that endogenous substrates may be an important 
source of cancer inducing damage to cellular DNA as the 
* Corresponding author Tel +91-571-700741, fax +91-571-
400466 
E mail address smhadi@del6 vsnl net in (N Hadi) 
adducts formed may contribute to the etiology of genetic 
disease and theiein the baseline of human cancer 
In this laboratory it has been pieviously shown that L-
DOPA causes DNA breakage in vitio in the presence of 
tiansition metals such as Cu(II) and that the reduction is 
catalyzed by the formation of reactive oxygen species such 
as the hydroxyl radical [8] Copper is known to be a normal 
component of chromatin and is available for internucleoso 
mal DNA fragmentation in isolated nuclei [1 ] Spencer et al 
[16] have pioposed that copper ions leleased in the presence 
of L-DOPA and its metabolites may be an important mechan-
ism of neurotoxicity in several neurological disordeis 
An important neuiotransmitter in brain and spinal coid is 
5-hydroxytryptamine or serotonin Serotonin is involved in 
the control of sleep and consciousness, aggressjpn and mood 
and IS implicated in disturbances such as anxiety anH depres-
sion Indeed, the stiucturally related hormone and drug mela-
tonin IS currently prescribed to regulate sleep disorders In a 
recent report it has been shown that copper ions are capable of 
binding to melatonin and serotonin [10] It was therefore of 
interest to examine whether serotonin may cauffDNA clea-
vage in the presence of copper ions through an oxidative 
mechanism In this paper, we descnbe experiments to show 
that this is indeed the case and that such DNA breakage 
results from the generation of the hydroxyl radical In ordei 
0304-3940/01/$ - see front matter © 2001 Elsevier Science Ireland Ltd All rights reserved 
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to determine the structural features of the serotonin molecule 
required for the DNA cleavage activity we have also 
compared the relative DNA cleavage and copper binding 
ability of serotonin with its precursor tryptophan and the 
related compound melatonin (Fig. 1). 
Calf thymus DNA (sodium salt, average M.W. 1 X lO''), 
serotonin and S, nuclease were from Sigma (St. Louis, MO). 
Supercoiled plasmid pBR322 DNA was prepared according 
to standard methods [II]. Allotherchemicals were of analy-
tical grade. 
Formation of strand breaks by serotonin-Cu(Il) was 
assayed by the extent of generation of S| nuclease sensitive 
sites in calf thymus DNA [14). Strand cleavage was further 
as.sayed by the decrease in superhelicity of supercoiled plas-
mid pBR322 DNA [8]. Reacti9n mixtures (30 |xl) contained 
10 mM Tris-HCl (pH 7.5), 0.50 jjig plasmid DNA and vary-
ing concentrations of .serotonin. Incubation was al room 
temperature for 1-2 h. Hydroxy 1 radicals were assayed by 
incubating a solution containing 2.0 mM salicylate and 15 
mM potassium phosphate buffer, (pH 8.0), serotonin, cupric 
chloride and other components in a total volume of 2.0 ml for 
2 h at room temperature. Salicylate was converted to hydro-
xylated products, which were extracted and determined 
colourimetrically [I5j. The stoichiometry of Cii(l) produc-
tion in the serotonin-Cu(lI) reaction was determined by titrat-
ing with bathocuproine as follows: serotonin (10 or 20 (JLM) 
in 10 mM Tris-HCl, (pH 7.5) was mixed with increasing 
concentrations of Cu(ll) and bathocuproine (a Cu(l) specific 
chelating agent) with a final concentration of 400 fj.M in a 
total volume of 1.5 ml. Absorbance was recorded at 480 nm. 
DNA cleavage by serotonin and Cu({I) was detected by 
using supercoiled pBR322 plasmid DNA as the relaxation 
of such a molecule is a sensitive test for a single nick. The 
results in Fig. 2A show that serotonin converted supercoiled 
DNA to relaxed open circles in a dose dependent manner. 
Under the conditions used and in the presence of 100 p-M 
Cu(II) the full conversion to relaxed circles was seen with 
200 [xM serotonin. Similar dose dependent results are seen 
with increasing Cu(II) concentrations (results not given). 
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Fig. 1. Structures of serotonin, t ryptophan and melatonin. 
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Fig. 2. Agarose gel electrophoretic pattern of supercoiled pBR 
322 DNA after t reatment w i th (A) serotonin and Cu(ll). Lane 1, 
DNA alone; Lanes 2-6, 10, 25, 50, 100, 200 (xM serotonin in the 
presence of 100 (J.M CU (II); Lane 7, DNA -1- Cufll). The reaction 
mixture was incubated at room temperature for 1 h. (B) Seroto-
n in, melatonin and t ryptophan (all 100 ixM) in the presence of 
Cu(ll) (100 fjLM). Lane 1, DNA alone; Lane 2, DNA + serotonin; 
Lane 3, DNA + serotonin + Cu(ll); Lane 4, DNA + melatonin; 
Lane 5, DNA + melatonin + Cu{ll); Lane 6, DNA + t ryptophan; 
Lane 7, DNA + t ryptophan 4- Cu(ll). The reaction mixture was 
incubated at room temperature for 2 h. 
In order to examine the involvement of Cu(l) in the reac-
tion we u.sed bathocuproine as an agent that sequesters Cu(I) 
selectively. Serotonin reduces Cu(II) to generate Cu(I) as 
evidenced by the formation of a complex absorbing at 480 
nm (results not shown) [14]. To determine the stoichiometry 
of Cu(ll) reduction by serotonin the experiment given in Fig. 
3 was carried out. A Job plot [14] of absorbance at 480 nm 
versus Cu(II)/serotonin molar ratio showed the maximum 
absorbance at a molar ratio of 2 at two different concentra-
tions (10 and 20 |JLM) of serotonin. This implies a 2:1 stoi-
chiometry for the reduction of Cu(II) by free serotonin. 
Fig. 4 shows that serotonin-Cu(ll) complex generates 
hydroxyl radicals as evidenced by aromatic hydroxylation 
of .salicylate. In the presence of Cu(II) and with increasing 
concentrations of serotonin an increasing degree of hydro-
xyl radical formation is seen. In the absence of Cu(II) the 
hydroxyl radical formation is considerably reduced. It has 
been shown previously that Cu(II) alone does not lead to the 
production of hydroxyl radical [5]. The most probable 
mechanism for the formation of the hydroxyl radical is 
through the formation of superoxide anion and consequent 
generation of hydrogen peroxide [7]. Hydrogen peroxide in 
the presence of Cu(I) gives rise to the hydroxyl radical 
(Fenton reaction). When a solution of serotonin is excited 
at 280 nm it exhibits a fluorescence ernission spectrum with 
a maximum around 335 nm. The addition of DNA to sero-
tonin causes a decrease in fluorescence emission, and a 
decreasing degree of fluorescence is seen with increasing 
concentrations of DNA (results not shown). The results indi-
N Hadi et al / Neuroscience Letters 308 (2001) 83-86 85 
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Table 1 
Degradation of calf thymus DNA by L DOPA, serotonin, nnelato 
nin and tryptophan in the presence of Cu(ll) as measured by the 
degree of S, nuclease digest ion^ 
0 2 A 6 
C u ( I l ) / S e r o f o n i n 
Fig 3 Stoichiometry of the interaction between Cu(ll) and sero 
tonin concentrations of 10 (xM ( • ) and 20 \i.U U ) The difference 
in absorbance at 480 nm of samples wi th and wi thout added 
Cu(ll) IS plotted versus molar equivalents of Cu(ll) per molar 
equivalent serotonin Both curves correspond to two equivalents 
Cu(ll) to one equivalent serotonin 
cate that simildi lo L DOPA [8], serotonin is also capable of 
binding to DNA 
In oidei to examine the chemical basis of the DNA clea-
vage activity ot seiotonin-Cu(lI) complex the relative effi-
ciency of serotonin was compared with the structuially 
lelated metabolites tryptophan and melatonin Fig 2B 
shows that when all the thiee metabolites were incubated 
with plasmid DNA alone they did not cause any conversion 
to relaxed open circles (lanes 2, 4 and 6) However, when 
copper was included in the reaction, full conversion to the 
open circular form was seen with serotonin only (lane 3) 
wheieas some conversion (up to about 50%) was also 
I 
"5. 
I 
Serotonin (\M) 
Fig 4 Formation of hydroxy! radicals as a funct ion of serotonin 
concentration ( • ) serotonin in the presence of 100 (xM Cu(ll), (O) 
in the absence of Cu(ll) The reaction mixtures were incubated 
for 2 h at room temperature 
Reaction Mixture % DNA hydrolyzed 
D N A + Cu(ll) + L DOPA 4 84 + 0 1 9 
DNA + Cu(ll) + serotonin 2 16 ± 0 08 
DNA + Cu(ll) + melatonin 0 00 
D N A + Cu(ll) + t r yp tophan 0 00 
° DNA was incubated w i t h the compounds (200 |xM) in the 
presence of 200 |JLM CU( I I ) at room temperature for 2 h Si nucie 
ase digestion and determinat ion of acid soluble material was 
done as described previously [14] Results are Mean ± SEM of 
four different experiments 
obseived in the case of melatonin (lane 5) and tryptophan 
(lane 7) However, copper alone caused considerably less 
conveision (Fig 2A, lane 7) These results were fuither 
confirmed by the assay using S, nuclease hydrolysis [14] 
This assay, although being less sensitive, allows quantita-
tion of DNA hydiolysis The results shown in Table 1 
compare the DNA hydrolysis by L-DOPA [8], serotonin 
melatonin and tryptophan The largest extent of hydiolysis 
IS seen in the case ot L-DOPA followed by serotonin 
N^heieas melatonin and tiyptophan do not show any activity 
In oidei to deteiinine whether serotonin and the related 
metabolites melatonin and tryptophan bind copper ions, 
the UV absorption spectrum was recorded in the presence 
and absence ot Cu(II) Results given in Fig 5 show that on 
addition of Cu(II) an enhancement of the serotonin absorp-
tion band is observed indicating an interaction of copper 
ions with serotonin However, the spectrum of melatonin 
and tryptophan does not exhibit any difference in the 
presence of coppei ions These results correlate with the 
ability of serotonin-Cu(II) complex to degrade DNA 
The principal conclusions of the above experiments may 
be stated as follows (i) the neurotransmitter serotonin is 
capable of causing DNA cleavage in the presence of copper 
ions through the generation of reactive oxygen species such 
as the hydroxyl radical, (u) this property of serotonin can be 
almost entirely attributed to the phenolic group as the meth-
oxylation of this group in melatonin considerably 
diminishes the DNA cleavage activity DNA damage by 
hydroxyl radicals is well established It is recognized by 
most workers that hydroxyl radical reactions with DNA 
are preceded by the association of a complex with DNA, 
followed by the production of hydroxyl radicals in situ [13] 
As shown above, serotonin is capable of binding to DNA 
and copper ions and since copper is an essential component 
of chromatin [I] the formation of a ternary complex of 
serotonin-Cu(II)-DNA is possible Possibly, this is the 
reason why hydroxyl radicals produced by serotonin alone 
do not lead to DNA cleavage (Fig 2B) Several classes of 
endogenous adducts and modified bases have been detected 
in DNA of normal cells These include oxidized, alkylated 
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Fig 5 Absorption spectrum of (a) serotonin, (b) melatonin and 
(c) tryptophan (all 50 \iM) in the presence ( ) and absence 
( )of CudDdOO^M) 
and exocyclic bases and a series of unidentified adducts 
called I-compounds [2] Generation of oxidized bases such 
as 8-hydroxyguanosine by reaction of DNA with intracel-
lular oxidants is quantitatively the most important class of 
base modification occurring in mammalian cells Progres-
sive accumulation of genetic mutations is thought to be 
central to the process of tumongenesis and aging [6] 
Most of the critical genes that are mutated during the devel-
opment of human cancer can be broadly classified as either 
proto-oacogenes or tumor suppressor genes [17] Although 
the concentrations of serotonin used in the above experi-
ments (10 \iM and above) do not approach the in vivo levels 
(0 2-1 14 jxM in blood), DNA breakage in presence of 
copper ions is also shown by other metabolites [8,9] It is 
conceivable that the cumulative effect of such endogenous 
metabolites could be of physiological significance and could 
contribute to the etiology of genetic disease 
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